Second Sight Medical Products (EYES) Stock Rises 25.88% This Week: What’s Next?

 

Shares of Second Sight Medical Products Inc (EYES) stock jumped nearly 24% Wednesday and are up more than 40% over the past 30 days. EYES stock has fallen -38.51% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives EYES stock a score of 76 out of a possible 100.

That score is primarily influenced by a fundamental score of 91. In addition to the average rating from Wall Street analysts, EYES stock has a mean target price of $2.50. This means analysts expect the stock to rise 133.64% over the next 12 months. EYES’s score also includes a short-term technical score of 79. The long-term technical score for EYES is 58.

Click Here to get the full Stock Score Report on Second Sight Medical Products Inc (EYES).

What’s Happening with EYES Stock Today

Second Sight Medical Products Inc (EYES) stock is lower by -6.14% while the S&P 500 is up 0.14% as of 11:05 AM on Thursday, Apr 11. EYES has fallen -$0.07 from the previous closing price of $1.14 on volume of 471,132 shares. Over the past year the S&P 500 is up 8.86% while EYES has fallen -38.51%. EYES lost -$0.53 per share in the over the last 12 months.

Symbols: EYES

You May Also Like